Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/46588
Campo DC Valoridioma
dc.contributor.authorSolé-Violán, Jordien_US
dc.contributor.authorGarcía-Laorden, M. Isabelen_US
dc.contributor.authorMarcos-Ramos, José Albertoen_US
dc.contributor.authorRodríguez De Castro, Felipeen_US
dc.contributor.authorRajas, Olgaen_US
dc.contributor.authorBorderías, Luisen_US
dc.contributor.authorBriones, M. Luisaen_US
dc.contributor.authorHerrera-Ramos, Estefaníaen_US
dc.contributor.authorBlanquer, Joséen_US
dc.contributor.authorAspa, Javieren_US
dc.contributor.authorFlorido, Yaniraen_US
dc.contributor.authorGarcía-Bello, Miguel Angelen_US
dc.contributor.authorFerrer-Agüero, José Maríaen_US
dc.contributor.authorSologuren, Ithaisaen_US
dc.contributor.authorRodriguez-Gallego, Carlosen_US
dc.date.accessioned2018-11-23T06:03:48Z-
dc.date.available2018-11-23T06:03:48Z-
dc.date.issued2011en_US
dc.identifier.issn0090-3493en_US
dc.identifier.urihttp://hdl.handle.net/10553/46588-
dc.description.abstractObjective: To assess the potential association of the functional polymorphism rs1801274 in the receptor IIa for the Fc portion of immunoglobin G (Fc gamma RIIa) gene (FCGR2A-H131R) with the susceptibility to and the severity of community-acquired pneumonia (CAP).Design: Multicenter prospective and observational study.Setting: Four university hospitals in Spain.Patients: FCGR2A-H131R polymorphism was determined in 1,262 patients with CAP and in 1,224 in the subject control group.Measurements and Main Results: Severe sepsis was recorded in 366 patients. No significant differences in genotype or allele frequencies were seen among patients with CAP or pneumococcal CAP (PCAP) and controls. Patients with bacteremic PCAP (B-PCAP) had significantly higher frequencies of FCGR2A-H/H131 genotypes than those with nonbacteremic PCAP (p = .00016, odds ratio = 2.9, 95% confidence interval 1.58-5.3). The differences remained significant when adjusting for pneumonia severity index, hospital of origin, and intensive care unit admission (p = .0012, odds ratio = 2.83, 95% confidence interval 1.51-5.32). B-PCAP was associated with a significantly higher severity of the disease, evaluated as sepsis severity (p = .000007, odds ratio = 4.40, 95% confidence interval 2.31-8.39), multiorgan dysfunction syndrome (0.00048, odds ratio = 3.29, 95% confidence interval 1.69-6.41), intensive care unit admission, acute renal failure, and acute respiratory distress syndrome.Conclusions: Our results do not support a role of FCGR2A-H131R polymorphism in susceptibility to CAP or PCAP. However, we provide the insight that homozygosity for FCGR2A-H131 predisposes B-PCAP, which was associated with higher severity in our study.en_US
dc.languageengen_US
dc.relation.ispartofCritical Care Medicineen_US
dc.sourceCritical Care Medicine[ISSN 0090-3493],v. 39, p. 1388-1393en_US
dc.subject32 Ciencias médicasen_US
dc.subject320508 Enfermedades pulmonaresen_US
dc.subject320505 Enfermedades infecciosasen_US
dc.subject.otherC-Reactive Proteinen_US
dc.subject.otherMannose-Binding Lectinen_US
dc.subject.otherStreptococcus-Pneumoniaeen_US
dc.subject.otherIgg Subclassesen_US
dc.subject.otherCapsular Polysaccharideen_US
dc.subject.otherInfectious-Diseasesen_US
dc.subject.otherHuman Monocytesen_US
dc.subject.otherRiiaen_US
dc.subject.otherPolymorphismsen_US
dc.subject.otherChildrenen_US
dc.titleThe Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumoniaen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1097/CCM.0b013e31820eda74en_US
dc.identifier.scopus79957651836-
dc.identifier.isi000290715000023-
dc.contributor.authorscopusid24391710100-
dc.contributor.authorscopusid6506073949-
dc.contributor.authorscopusid24390906800-
dc.contributor.authorscopusid55942667000-
dc.contributor.authorscopusid6505890335-
dc.contributor.authorscopusid16168865800-
dc.contributor.authorscopusid7006010004-
dc.contributor.authorscopusid36952964800-
dc.contributor.authorscopusid7004176630-
dc.contributor.authorscopusid6602555827-
dc.contributor.authorscopusid36953039500-
dc.contributor.authorscopusid36099016000-
dc.contributor.authorscopusid16063032700-
dc.contributor.authorscopusid36451076500-
dc.contributor.authorscopusid6602114379-
dc.description.lastpage1393en_US
dc.description.firstpage1388en_US
dc.relation.volume39en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid31934158-
dc.contributor.daisngid8480501-
dc.contributor.daisngid6436106-
dc.contributor.daisngid464249-
dc.contributor.daisngid1134484-
dc.contributor.daisngid857548-
dc.contributor.daisngid1423003-
dc.contributor.daisngid2130906-
dc.contributor.daisngid323613-
dc.contributor.daisngid952601-
dc.contributor.daisngid5970874-
dc.contributor.daisngid1700450-
dc.contributor.daisngid5136129-
dc.contributor.daisngid2746635-
dc.contributor.daisngid603384-
dc.description.numberofpages6en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Sole-Violan, J-
dc.contributor.wosstandardWOS:Garcia-Laorden, MI-
dc.contributor.wosstandardWOS:Marcos-Ramos, JA-
dc.contributor.wosstandardWOS:de Castro, FR-
dc.contributor.wosstandardWOS:Rajas, O-
dc.contributor.wosstandardWOS:Borderias, L-
dc.contributor.wosstandardWOS:Briones, ML-
dc.contributor.wosstandardWOS:Herrera-Ramos, E-
dc.contributor.wosstandardWOS:Blanquer, J-
dc.contributor.wosstandardWOS:Aspa, J-
dc.contributor.wosstandardWOS:Florido, Y-
dc.contributor.wosstandardWOS:Garcia-Bello, MA-
dc.contributor.wosstandardWOS:Ferrer-Aguero, JM-
dc.contributor.wosstandardWOS:Sologuren, I-
dc.contributor.wosstandardWOS:Rodriguez-Gallego, C-
dc.date.coverdateEnero 2011en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr3,083
dc.description.jcr6,33
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Patología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-6812-2739-
crisitem.author.orcid0000-0002-4344-8644-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez De Castro, Felipe Carlos B.-
crisitem.author.fullNameRodríguez Gallego, José Carlos-
Colección:Artículos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.